These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12411788)

  • 21. Homozygous and heterozygous Arg614Cys mutations (1840C-->T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family.
    Rueffert H; Olthoff D; Deutrich C; Thamm B; Froster UG
    Br J Anaesth; 2001 Aug; 87(2):240-5. PubMed ID: 11493496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.
    Stewart SL; Hogan K; Rosenberg H; Fletcher JE
    Clin Genet; 2001 Mar; 59(3):178-84. PubMed ID: 11260227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
    Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
    Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation.
    Fagerlund TH; Ording H; Bendixen D; Islander G; Ranklev Twetman E; Berg K
    Clin Genet; 1997 Dec; 52(6):416-21. PubMed ID: 9520251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA testing for malignant hyperthermia: the reality and the dream.
    Stowell KM
    Anesth Analg; 2014 Feb; 118(2):397-406. PubMed ID: 24445638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
    Steinfath M; Scholz J; Singh S; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies.
    Quane KA; Keating KE; Manning BM; Healy JM; Monsieurs K; Heffron JJ; Lehane M; Heytens L; Krivosic-Horber R; Adnet P
    Hum Mol Genet; 1994 Mar; 3(3):471-6. PubMed ID: 8012359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Løseth S; Voermans NC; Torbergsen T; Lillis S; Jonsrud C; Lindal S; Kamsteeg EJ; Lammens M; Broman M; Dekomien G; Maddison P; Muntoni F; Sewry C; Radunovic A; de Visser M; Straub V; van Engelen B; Jungbluth H
    J Neurol; 2013 Jun; 260(6):1504-10. PubMed ID: 23329375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
    Kraeva N; Sapa A; Dowling JJ; Riazi S
    Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families.
    Barone V; Massa O; Intravaia E; Bracco A; Di Martino A; Tegazzin V; Cozzolino S; Sorrentino V
    J Med Genet; 1999 Feb; 36(2):115-8. PubMed ID: 10051009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of
    Sadhasivam S; Brandom BW; Henker RA; McAuliffe JJ
    Pharmacogenomics; 2019 Sep; 20(14):989-1003. PubMed ID: 31559918
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
    Beam TA; Loudermilk EF; Kisor DF
    Physiol Genomics; 2017 Feb; 49(2):81-87. PubMed ID: 28011884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of malignant hyperthermia in Denmark and Sweden.
    Ording H; Ranklev E; Fletcher R
    Br J Anaesth; 1984 Nov; 56(11):1183-90. PubMed ID: 6487440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.
    Iles DE; Lehmann-Horn F; Scherer SW; Tsui LC; Olde Weghuis D; Suijkerbuijk RF; Heytens L; Mikala G; Schwartz A; Ellis FR
    Hum Mol Genet; 1994 Jun; 3(6):969-75. PubMed ID: 7951247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families.
    Iles DE; Segers B; Heytens L; Sengers RC; Wieringa B
    Genomics; 1992 Nov; 14(3):749-54. PubMed ID: 1427902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.